Prescription of Opioid Analgesics for Chronic Non-Cancer Pain in Germany despite Contraindications: Administrative Claims Data Analysis
Authors:
- Anja NiemannANAnja Niemann
- Nils F. SchraderNSNils F. Schrader
- Christian SpeckemeierCSChristian Speckemeier
- Carina AbelsCACarina Abels
- Nikola BlaseNBNikola Blase
- Milena WeitzelMWMilena Weitzel
- Anja NeumannANAnja Neumann
- Cordula RiedererCRCordula Riederer
- Joachim NadstawekJNJoachim Nadstawek
- Wolfgang StraßmeirWSWolfgang Straßmeir
- Jürgen WasemJWJürgen Wasem
- Silke NeusserSNSilke Neusser
Open Access
- 5 February 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 21 (2) , 180
Abstract
In Germany, long-term opioid treatment (L-TOT) for chronic non-tumor pain (CNTP) is discussed as not being performed according to the German guideline on L-TOT for CNTP. In the present analysis, the occurrence and predictors of inappropriate care/overuse in a cohort of German insureds with L-TOT for CNTP by the presence of a contraindication with concurrent opioid analgesic (OA) therapy were investigated. We also analyzed whether prescribing physicians themselves diagnosed a contraindication. The retrospective cohort study was based on administrative claims data from a German statutory health insurance. Eight contraindication groups were defined based on the German guideline. Logistic regressions were performed in order to identify predictors for OA prescriptions despite contraindications. The possible knowledge of the prescribing physician about the contraindication was approximated by analyzing concordant unique physician identification numbers of OA prescriptions and contraindication diagnoses. A total of 113,476 individuals (75% female) with a mean age of 72 years were included. The most common documented contraindications were primary headaches (8.7%), severe mood disorders (7.7%) and pain in somatoform disorders (4.5%). The logistic regressions identified a younger age, longer history of OA therapy, opioid related psychological problems, and outpatient psychosomatic primary care as positive predictors for all contraindication groups.Keywords
Funding Information
- Innovation Fund of the Joint Federal Committee of Germany (01VSF19059)
- University of Duisburg-Essen (01VSF19059)
This publication has 9 references indexed in Scilit:
- Prescription of opioid analgesics for non-cancer pain in Germany: study protocol for a mixed methods analysisJournal of Public Health, 2022
- Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal studyThe Lancet Public Health, 2022
- Empfehlungen der zweiten Aktualisierung der Leitlinie LONTSDer Schmerz, 2020
- Long‐term opioid therapy definitions and predictors: A systematic reviewPharmacoepidemiology and Drug Safety, 2019
- Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidencePLOS ONE, 2019
- Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015MMWR. Morbidity and Mortality Weekly Report, 2017
- CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016JAMA, 2016
- Utilisation des opioïdes forts dans la douleur chronique non cancéreuse chez l’adulte. Recommandations françaises de bonne pratique clinique par consensus formalisé (SFETD)La Presse Médicale, 2016
- Nutzungsmöglichkeiten von Routinedaten der Gesetzlichen Krankenversicherung in der Gesundheitsberichterstattung des BundesBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2014